Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
Cited by 34
Related Papers
The Burden of Treatment Failure in Type 2 Diabetes
|Diabetes Care|2004|426
Physical Activity Over the Lifecourse and Cardiovascular Disease
|Circulation Research|2023|159
An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial
|The Lancet|2015|131